Insider Trading History of Nashat Amir


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Nashat Amir since year 2005. The trader's CIK number is 1575843. At the time of the last reporting, Nashat Amir was the Director of Fate Therapeutics Inc . (stock ticker symbol FATE). See this page for all insider trading activities at Fate Therapeutics Inc .

Note that in the past Nashat Amir also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Nashat Amir since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2019-08-01 FATE Fate Therapeutics Inc Sale 30,866 22.53 695,380
2019-07-31 FATE Fate Therapeutics Inc Sale 31,139 22.53 701,686
2019-07-26 FATE Fate Therapeutics Inc Sale 27,829 22.50 626,152
2019-07-29 FATE Fate Therapeutics Inc Sale 329 22.50 7,402
2019-07-30 FATE Fate Therapeutics Inc Sale 90,175 22.51 2,029,568
2019-07-23 FATE Fate Therapeutics Inc Sale 62,033 22.50 1,396,052
2019-07-24 FATE Fate Therapeutics Inc Sale 19,866 22.51 447,104
2019-07-22 FATE Fate Therapeutics Inc Sale 48,704 22.52 1,097,008
2019-07-19 FATE Fate Therapeutics Inc Sale 1,053 22.50 23,692
2019-07-18 FATE Fate Therapeutics Inc Sale 21,409 22.50 481,788
2019-07-01 MORF Morphic Holding, Inc. Buy 125,000 15.00 1,875,000
2019-01-30 FATE Fate Therapeutics Inc Sale 53,017 14.16 750,985
2019-01-29 FATE Fate Therapeutics Inc Sale 97,500 14.16 1,380,795
2019-01-28 FATE Fate Therapeutics Inc Sale 70,000 13.78 964,740
2019-01-25 SELB Selecta Biosciences Inc Buy 1,166,666 1.50 1,749,999
2019-01-25 FATE Fate Therapeutics Inc Sale 90,000 14.14 1,272,780
2019-01-18 FATE Fate Therapeutics Inc Sale 39,483 16.28 642,822
2018-12-20 FATE Fate Therapeutics Inc Sale 33,474 12.25 410,156
2018-12-19 FATE Fate Therapeutics Inc Sale 91,210 13.58 1,238,358
2018-12-13 FATE Fate Therapeutics Inc Sale 17,788 16.67 296,561
2018-12-12 FATE Fate Therapeutics Inc Sale 425,000 16.78 7,132,775
2018-12-11 FATE Fate Therapeutics Inc Sale 82,528 16.71 1,379,207
2018-05-29 SRRK Scholar Rock Holding Corp Buy 142,857 14.00 1,999,998
2017-09-26 SELB Selecta Biosciences Inc Sale 70,226 18.91 1,328,114
2017-09-22 SELB Selecta Biosciences Inc Sale 42,036 19.26 809,781
2017-09-25 SELB Selecta Biosciences Inc Sale 37,175 18.99 705,878
2017-09-21 SELB Selecta Biosciences Inc Sale 104,577 19.86 2,076,794
2017-09-20 SELB Selecta Biosciences Inc Sale 42,610 20.03 853,393
2016-07-06 SYRS Syros Pharmaceuticals, Inc. Buy 400,000 12.50 5,000,000
2016-06-27 SELB Selecta Biosciences Inc Buy 150,000 14.00 2,100,000
2013-12-06 RCPT Receptos, Inc. Sale 170,000 27.29 4,639,300
2013-11-20 RCPT Receptos, Inc. Sale 30,685 22.77 698,697
2013-11-14 RCPT Receptos, Inc. Sale 154,089 25.00 3,852,225
2013-11-15 RCPT Receptos, Inc. Sale 15,226 24.54 373,646
2013-10-04 FATE Fate Therapeutics Inc Buy 833,333 6.00 4,999,998
2013-05-14 RCPT Receptos, Inc. Buy 151,343 14.00 2,118,802

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Nashat Amir (Director of Fate Therapeutics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.




Real-time Insider Trading

Insider Officer Cluster Trading

Top Officer Buys of the Week

Top Officer Buys of the Month